We are live on ! Find out more
CC

Callan Capital Portfolio holdings

AUM $1.35B
1-Year Est. Return 8.35%
This Fund
S&P 500
This Quarter Est. Return
+11.93%
1 Year Est. Return
+8.35%
3 Year Est. Return
+20.11%
5 Year Est. Return
+98.58%
10 Year Est. Return
+95.87%
AUM
$470M
AUM Growth
+$29.3M
Cap. Flow
-$17.8M
Cap. Flow %
-3.78%
Top 10 Hldgs %
73.69%
Holding
76
New
3
Increased
26
Reduced
21
Closed
8

Sector Composition

Rank Sector Weight
1 Miscellaneous 97.16%
2 Healthcare 1.75%
3 Real Estate 0.45%
4 Consumer Staples 0.2%
5 Materials 0.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAXJ icon
26
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.88B
$2.35M 0.5%
36,653
-209
-0.6% -$13.1K
IWB icon
27
iShares Russell 1000 ETF
IWB
$49.1B
$1.92M 0.41%
16,584
-857
-5% -$99K
BIIB icon
28
Biogen
BIIB
$32.3B
$1.91M 0.41%
4,526
IYF icon
29
iShares US Financials ETF
IYF
$4.31B
$1.89M 0.4%
42,504
-1,562
-4% -$69.4K
CMBS icon
30
iShares CMBS ETF
CMBS
$472M
$1.59M 0.34%
30,416
-4,239
-12% -$220K
EBND icon
31
State Street SPDR Bloomberg Emerging Markets Local Bond ETF
EBND
$2.29B
$1.58M 0.34%
58,141
SJNK icon
32
State Street SPDR Bloomberg Short Term High Yield Bond ETF
SJNK
$4.8B
$1.55M 0.33%
53,235
-4,423
-8% -$129K
XLB icon
33
State Street Materials Select Sector SPDR ETF
XLB
$8.81B
$1.5M 0.32%
61,530
-1,002
-2% -$24.8K
BMR
34
DELISTED
BIOMED REALTY TRUST INC
BMR
$1.46M 0.31%
64,584
+4,415
+7% +$101K
RLY icon
35
State Street Multi-Asset Real Return ETF
RLY
$1.35B
$1.41M 0.3%
53,936
+204
+0.4% +$5.44K
XLU icon
36
State Street Utilities Select Sector SPDR ETF
XLU
$21.9B
$1.33M 0.28%
59,956
+30
+0.1% +$693
MLPX icon
37
Global X MLP & Energy Infrastructure ETF
MLPX
$3.63B
$1.33M 0.28%
23,609
-2,058
-8% -$113K
SGYP
38
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$1.21M 0.26%
261,222
+19,877
+8% +$64.6K
ARNA
39
DELISTED
Arena Pharmaceuticals Inc
ARNA
$1.15M 0.24%
26,200
+8,095
+45% +$376K
SQNM
40
DELISTED
SEQUENOM INC NEW
SQNM
$1.05M 0.22%
266,477
ZVO
41
DELISTED
Zovio Inc. Common Stock
ZVO
$950K 0.2%
98,418
-30,000
-23% -$302K
HALO icon
42
Halozyme
HALO
$12B
$920K 0.2%
64,431
-134,799
-68% -$1.94M
VV icon
43
Vanguard Morningstar Large-Cap ETF
VV
$54.3B
$901K 0.19%
9,466
DBC icon
44
Invesco DB Commodity Index Tracking Fund
DBC
$1.82B
$888K 0.19%
+52,021
New +$916K
AXJL
45
DELISTED
WisdomTree Asia-Pacific ex-Japan Fund
AXJL
$862K 0.18%
12,842
NBIX icon
46
Neurocrine Biosciences
NBIX
$15.7B
$794K 0.17%
20,000
-7,365
-27% -$263K
MON
47
DELISTED
Monsanto Co
MON
$686K 0.15%
6,098
ARE icon
48
Alexandria Real Estate Equities
ARE
$8.87B
$638K 0.14%
6,509
KND
49
DELISTED
Kindred Healthcare
KND
$630K 0.13%
26,468
DSI icon
50
iShares MSCI KLD 400 Social ETF
DSI
$5.53B
$507K 0.11%
13,138
-2,294
-15% -$88.1K

Similar funds

Callan Capital's Q1 2015 Portfolio in Review

As of Q1 2015, Callan Capital held 76 positions worth $470M, up 6.7% from $441M the previous quarter. Its ten largest holdings account for 74% of the portfolio.

Callan Capital withdrew a net $17.8M in Q1 2015, closing 8 positions and reducing 21 holdings. Its most notable exit was iShare MSCI Eurozone ETF, an estimated $2.93M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 97% of assets, up from 96% a quarter earlier, followed by Healthcare and Real Estate.

Against the trend, Callan Capital opened a new position in Invesco DB Commodity Index Tracking Fund worth $888K.

  • Callan Capital's largest Q1 2015 buy was Invesco DB Commodity Index Tracking Fund: 52,021 shares worth $888K.
  • Callan Capital added most to First Trust Global Tactical Commodity Strategy Fund in Q1 2015, an estimated $4.72M increase.
  • Callan Capital's biggest Q1 2015 reduction was Halozyme, cutting an estimated $1.94M.
  • Callan Capital fully exited iShare MSCI Eurozone ETF in Q1 2015, selling an estimated $2.93M.
  • Callan Capital's ten largest holdings make up 74% of its $470M portfolio in Q1 2015.
  • Callan Capital opened 3 new positions and closed 8 in Q1 2015.
  • Callan Capital's portfolio value rose 6.7% quarter-over-quarter to $470M.

Based on Callan Capital's 13F filing for Q1 2015, filed 11 May 2015.